Wan-Mui Chan

4.1k total citations · 2 hit papers
26 papers, 1.4k citations indexed

About

Wan-Mui Chan is a scholar working on Infectious Diseases, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wan-Mui Chan has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 4 papers in Hepatology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wan-Mui Chan's work include SARS-CoV-2 and COVID-19 Research (17 papers), SARS-CoV-2 detection and testing (14 papers) and Viral gastroenteritis research and epidemiology (8 papers). Wan-Mui Chan is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (17 papers), SARS-CoV-2 detection and testing (14 papers) and Viral gastroenteritis research and epidemiology (8 papers). Wan-Mui Chan collaborates with scholars based in Hong Kong, China and Canada. Wan-Mui Chan's co-authors include Kwok‐Yung Yuen, Kelvin Kai‐Wang To, Jonathan Daniel Ip, Allen Wing‐Ho Chu, Kwok‐Hung Chan, Vincent Chi‐Chung Cheng, Ivan Fan‐Ngai Hung, Hoi‐Wah Tsoi, Honglin Chen and Wing‐Kin To and has published in prestigious journals such as Nature Communications, Clinical Infectious Diseases and Journal of Hazardous Materials.

In The Last Decade

Wan-Mui Chan

25 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing

2020 449 citations Kelvin Kai‐Wang To, Ivan Fan‐Ngai Hung et al. Clinical Infectious Diseases profile →
SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells

2021 257 citations Hanjun Zhao, Lu Lu et al. Emerging Microbes & Infections profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wan-Mui Chan Hong Kong	16	1.1k	228	173	157	128	26	1.4k
Evangelia Georgia Kostaki Greece	15	647 0.6×	117 0.5×	142 0.8×	140 0.9×	273 2.1×	44	1.0k
Peter K.C. Cheng China	17	1.0k 0.9×	44 0.2×	137 0.8×	197 1.3×	285 2.2×	20	1.4k
Dena Adachi Canada	11	750 0.7×	36 0.2×	156 0.9×	133 0.8×	382 3.0×	14	1.1k
Thomas Theo Brehm Germany	17	458 0.4×	71 0.3×	34 0.2×	127 0.8×	141 1.1×	63	785
Edward P K Parker United Kingdom	14	683 0.6×	95 0.4×	45 0.3×	209 1.3×	164 1.3×	48	977
Nancy S. Miller United States	20	568 0.5×	78 0.3×	43 0.2×	171 1.1×	411 3.2×	43	1.1k
Owen Tak‐Yin Tsang Hong Kong	11	768 0.7×	35 0.2×	52 0.3×	167 1.1×	171 1.3×	25	1.0k
Gabriel Reina Spain	18	397 0.3×	144 0.6×	94 0.5×	78 0.5×	508 4.0×	71	933
Lisa Oestereich Germany	22	1.3k 1.1×	24 0.1×	89 0.5×	135 0.9×	405 3.2×	47	1.5k
Andrea Sieberg Germany	8	1.0k 0.9×	17 0.1×	302 1.7×	71 0.5×	129 1.0×	9	1.2k

Countries citing papers authored by Wan-Mui Chan

Since Specialization

Citations

This map shows the geographic impact of Wan-Mui Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan-Mui Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan-Mui Chan more than expected).

Fields of papers citing papers by Wan-Mui Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan-Mui Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan-Mui Chan. The network helps show where Wan-Mui Chan may publish in the future.

Co-authorship network of co-authors of Wan-Mui Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Wan-Mui Chan. A scholar is included among the top collaborators of Wan-Mui Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan-Mui Chan. Wan-Mui Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ho, Su Ling, Shusheng Wu, Cyril Chik‐Yan Yip, et al.. (2025). Enhanced surveillance, subtyping, and host adaptation analysis reveal genotype-wide zoonotic potential of rat hepatitis E virus. Journal of Hepatology. 84(1). 51–61. 2 indexed citations

Zhang, Xiaojuan, Lin‐Lei Chen, Carol Ho-Yan Fong, et al.. (2025). Avian Influenza Virus A(H5N1) Genotype D1.1 Is Better Adapted to Human Nasal and Airway Organoids Than Genotype B3.13. The Journal of Infectious Diseases. 233(3). e662–e666.

Yip, Cyril Chik‐Yan, Kit‐Hang Leung, Wan-Mui Chan, et al.. (2024). Development and Evaluation of an In-House Real-Time RT-PCR Targeting nsp10 Gene for SARS-CoV-2 Detection. International Journal of Molecular Sciences. 25(6). 3552–3552. 1 indexed citations

Zhang, Xiaojuan, Jonathan Daniel Ip, Carol Ho-Yan Fong, et al.. (2024). Characterizing fitness and immune escape of SARS-CoV-2 EG.5 sublineage using elderly serum and nasal organoid. iScience. 27(5). 109706–109706. 5 indexed citations

Ip, Jonathan Daniel, Wan-Mui Chan, Allen Wing‐Ho Chu, et al.. (2024). The significance of recurrent de novo amino acid substitutions that emerged during chronic SARS-CoV-2 infection: an observational study. EBioMedicine. 107. 105273–105273. 1 indexed citations

Zhou, Runhong, Bo‐Hao Chen, Na Liu, et al.. (2024). Ultrapotent class I neutralizing antibodies post Omicron breakthrough infection overcome broad SARS-CoV-2 escape variants. EBioMedicine. 108. 105354–105354. 2 indexed citations

Ip, Jonathan Daniel, Allen Wing‐Ho Chu, Wan-Mui Chan, et al.. (2023). Global prevalence of SARS-CoV-2 3CL protease mutations associated with nirmatrelvir or ensitrelvir resistance. EBioMedicine. 91. 104559–104559. 65 indexed citations

Kok, Kin‐Hang, Shuk‐Ching Wong, Wan-Mui Chan, et al.. (2022). Co-circulation of two SARS-CoV-2 variant strains within imported pet hamsters in Hong Kong. Emerging Microbes & Infections. 11(1). 689–698. 29 indexed citations

Li, Xin, Anthony Raymond Tam, Wan-Mui Chan, et al.. (2022). Risk Factors for Slow Viral Decline in COVID-19 Patients during the 2022 Omicron Wave. Viruses. 14(8). 1714–1714. 6 indexed citations

10.

Chen, Lin‐Lei, Syed Muhammad Abdullah, Wan-Mui Chan, et al.. (2022). Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong. Nature Communications. 13(1). 3618–3618. 41 indexed citations

11.

Cheng, Vincent Chi‐Chung, David Christopher Lung, Shuk‐Ching Wong, et al.. (2022). Outbreak investigation of airborne transmission of Omicron (B.1.1.529) - SARS-CoV-2 variant of concern in a restaurant: Implication for enhancement of indoor air dilution. Journal of Hazardous Materials. 430. 128504–128504. 32 indexed citations

12.

Sridhar, Siddharth, Shusheng Wu, Jianwen Situ, et al.. (2022). A small animal model of chronic hepatitis E infection using immunocompromised rats. JHEP Reports. 4(10). 100546–100546. 17 indexed citations

13.

Sridhar, Siddharth, Jianwen Situ, Jian‐Piao Cai, et al.. (2021). Multimodal investigation of rat hepatitis E virus antigenicity: Implications for infection, diagnostics, and vaccine efficacy. Journal of Hepatology. 74(6). 1315–1324. 43 indexed citations

14.

Zhao, Hanjun, Kelvin Kai‐Wang To, Xinxin Zhou, et al.. (2021). Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2. Nature Communications. 12(1). 1517–1517. 49 indexed citations

15.

Ip, Jonathan Daniel, Kin‐Hang Kok, Wan-Mui Chan, et al.. (2020). Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain. Clinical Microbiology and Infection. 27(9). 1350.e1–1350.e5. 21 indexed citations

16.

Chu, Allen Wing‐Ho, Wan-Mui Chan, Jonathan Daniel Ip, et al.. (2020). Evaluation of simple nucleic acid extraction methods for the detection of SARS-CoV-2 in nasopharyngeal and saliva specimens during global shortage of extraction kits. Journal of Clinical Virology. 129. 104519–104519. 46 indexed citations

17.

To, Kelvin Kai‐Wang, Ivan Fan‐Ngai Hung, Jonathan Daniel Ip, et al.. (2020). Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing. Clinical Infectious Diseases. 73(9). e2946–e2951. 449 indexed citations breakdown →

18.

Chen, Lin‐Lei, Wai‐Lan Wu, Wan-Mui Chan, et al.. (2019). Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains. Epidemiology and Infection. 147. e279–e279. 5 indexed citations

19.

Sridhar, Siddharth, Cyril C. Y. Yip, Shusheng Wu, et al.. (2018). Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant. Emerging infectious diseases. 24(12). 2241–2250. 173 indexed citations

20.

To, Kelvin Kai‐Wang, Herman Tse, Wan-Mui Chan, et al.. (2014). A Novel Psittacine Adenovirus Identified During an Outbreak of Avian Chlamydiosis and Human Psittacosis: Zoonosis Associated with Virus-Bacterium Coinfection in Birds. PLoS neglected tropical diseases. 8(12). e3318–e3318. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact